Work

Structural, DNA/BSA binding interactions and cytotoxicity studies of carboxamide (pyridyl)pyrazine palladium(II) complexes

Year: 2024
Type: article
Abstract: : Reactions of ligands [ N 2 , N 3 -bis(pyridin-2-yl)pyrazine-2,3-dicarboxamide] ( L1 ), [ N 2 , N 3 -bis(6-methylpyridin-2-yl)pyrazine-2,3-dicarboxamide] ( L2 ), [ N 2 , N 3 -bis(4-methylpyridin-2-yl)pyrazine-2,3-dicarboxamide] ( L3 ) and [ N 2 , N 3 -bis(quinoline-8-yl)pyrazine-2,3-dicarboxamide] ( L4 ) with [PdCl 2 (NCMe) 2 ] afforded the respective palladium(II) complexes: [Pd 2 ( L1 ) 2 Cl 2 ] (Pd1) , [Pd 2 ( L2 ) 2 Cl 2 ] (Pd2) , [Pd 2 ( L3 ) 2 Cl 2 ] (Pd3) and [Pd( L4) Cl] (Pd4) . Molecular structures of complexes Pd1 and Pd3 are dinuclear containing two bridging bidentate ligand units. The interactions of the palladium complexes ( Pd1 - Pd4 ) with calf thymus DNA (CT-DNA) were monitored using UV–Vis and fluorescence spectroscopy and revealed intercalative binding modes, with intrinsic binding constants (K b ) in the order of 10 6 M −1 . Bovine serum albumin (BSA) interaction was evaluated using fluorescence techniques and displayed a static quenching mechanism. The cytotoxic effects of the complexes Pd1-Pd4 were examined against human breast cancer cell lines MCF-7 and MDA-MB-231, and human transformed lung cell line MRC5-SV2 (a model of lung cancer) and its parental normal lung fibroblast cell line MRC5. While the complexes Pd1 and Pd4 showed significant to moderate cytotoxicity against MCF-7 (IC 50 of 11.2 µM and 61.5 µM, respectively), complexes Pd2 and Pd3 were inactive. All the complexes were inactive against the MDA-MB-231 cell line, and Pd2-Pd4 were inactive against the MRC5-SV2 cell line. Compounds Pd1 exhibited lower cytotoxicity against the normal cell line MRC5.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,570
OpenAlex ID: W4403154478
FWCI: 1.676
Cites: 64
Cited by: 11
Related to: 10